Search research articles
Contact Us
Filters
Showing results (71-80 of 91) with videos related to
Page
of 10
Sort By:
Journal of Medicinal Chemistry
|
May 29, 2024
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure
Jeremy M Richter, Prashantha Gunaga, Navnath Yadav, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent
Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier, et al.
Journal of Medicinal Chemistry
|
August 31, 2022
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation
Alicia Regueiro-Ren, Sing-Yuen Sit, Yan Chen, et al.
Journal of Medicinal Chemistry
|
June 22, 2022
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4
E Scott Priestley, Jacques Banville, Daniel Deon, et al.
The Lancet. Infectious Diseases
|
September 26, 2024
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
Jonne Terstappen, Sarah F Hak, Anant Bhan, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer
Christine M Tarby, Amy Hart, Honghe Wan, et al.
Medchemcomm
|
August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators
David Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Journal of Medicinal Chemistry
|
December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor Modulator
Michael G Yang, Zili Xiao, T G Murali Dhar, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms
Honghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Journal of Medicinal Chemistry
|
May 24, 2025
Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity
Sayumi Yamazoe, Yam Poudel, Emanuela Sega, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 91) with videos related to
Sort By:
Page
of 10
Journal of Medicinal Chemistry
|
May 29, 2024
Discovery of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor for the Treatment of Heart Failure
Jeremy M Richter, Prashantha Gunaga, Navnath Yadav, et al.
ACS Medicinal Chemistry Letters
|
February 20, 2020
Discovery of BMS-986260, a Potent, Selective, and Orally Bioavailable TGFβR1 Inhibitor as an Immuno-oncology Agent
Upender Velaparthi, Chetan Padmakar Darne, Jayakumar Warrier, et al.
Journal of Medicinal Chemistry
|
August 31, 2022
The Discovery of GSK3640254, a Next-Generation Inhibitor of HIV-1 Maturation
Alicia Regueiro-Ren, Sing-Yuen Sit, Yan Chen, et al.
Journal of Medicinal Chemistry
|
June 22, 2022
Discovery of Two Novel Antiplatelet Clinical Candidates (BMS-986120 and BMS-986141) That Antagonize Protease-Activated Receptor 4
E Scott Priestley, Jacques Banville, Daniel Deon, et al.
The Lancet. Infectious Diseases
|
September 26, 2024
The respiratory syncytial virus vaccine and monoclonal antibody landscape: the road to global access
Jonne Terstappen, Sarah F Hak, Anant Bhan, et al.
ACS Medicinal Chemistry Letters
|
May 20, 2026
Discovery of BMS-159, an Orally Active Imidazotriazine Pan-CK2 Inhibitor for the Treatment of Cancer
Christine M Tarby, Amy Hart, Honghe Wan, et al.
Medchemcomm
|
August 16, 2018
Identification of potent tricyclic prodrug S1P<sub>1</sub> receptor modulators
David Marcoux, Hai-Yun Xiao, T G Murali Dhar, et al.
Journal of Medicinal Chemistry
|
December 23, 2016
Asymmetric Hydroboration Approach to the Scalable Synthesis of ((1R,3S)-1-Amino-3-((R)-6-hexyl-5,6,7,8-tetrahydronaphthalen-2-yl)cyclopentyl)methanol (BMS-986104) as a Potent S1P<sub>1</sub> Receptor Modulator
Michael G Yang, Zili Xiao, T G Murali Dhar, et al.
ACS Medicinal Chemistry Letters
|
August 20, 2015
Discovery of a Highly Selective JAK2 Inhibitor, BMS-911543, for the Treatment of Myeloproliferative Neoplasms
Honghe Wan, Gretchen M Schroeder, Amy C Hart, et al.
Journal of Medicinal Chemistry
|
May 24, 2025
Discovery and Characterization of a First-in-Class LIV1-TLR7/8 Immunomodulatory Conjugate with Robust Myeloid Activation and Antitumor Activity
Sayumi Yamazoe, Yam Poudel, Emanuela Sega, et al.
Page
of 10